Welcome to the MDS 2023 Congress Calendar

This Bristol Myers Squibb-sponsored satellite symposium will explore the latest practices in the management of lower-risk myelodysplastic syndromes (LR-MDS), from the perspectives of leading experts. First, the faculty will provide an update on the treatment paradigm for LR-MDS and the unmet needs of patients, in the first- and second-line settings. After summarizing key data from the latest clinical trials, the experts will then present real-world scenarios to provide the audience with an overview of current practice. The symposium will close with a Q&A session where the audience will have the opportunity to pose questions of interest to the faculty. Lunch will be provided outside the Auditorium.